Option Care Health (NASDAQ:OPCH) Given Outperform Rating at Barrington Research

Barrington Research reaffirmed their outperform rating on shares of Option Care Health (NASDAQ:OPCH - Free Report) in a research report released on Wednesday,Benzinga reports. They currently have a $38.00 price target on the stock. Barrington Research also issued estimates for Option Care Health's FY2025 earnings at $1.50 EPS, Q1 2026 earnings at $0.36 EPS, Q2 2026 earnings at $0.41 EPS and Q3 2026 earnings at $0.43 EPS.

Other equities analysts also recently issued research reports about the company. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research report on Tuesday, April 22nd. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. JPMorgan Chase & Co. raised their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Finally, Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and boosted their price target for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $35.50.

Option Care Health Trading Down 0.8 %

Shares of Option Care Health stock traded down $0.28 during trading on Wednesday, hitting $32.67. The stock had a trading volume of 891,682 shares, compared to its average volume of 1,823,116. Option Care Health has a 12 month low of $21.39 and a 12 month high of $35.53. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm's fifty day simple moving average is $33.35 and its 200-day simple moving average is $28.82. The stock has a market cap of $5.35 billion, a PE ratio of 27.42, a PEG ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.04. The business had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The firm's quarterly revenue was up 16.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.26 earnings per share. As a group, sell-side analysts expect that Option Care Health will post 1.22 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.64% of the stock is owned by company insiders.

Hedge Funds Weigh In On Option Care Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in OPCH. Jackson Creek Investment Advisors LLC bought a new stake in shares of Option Care Health in the 1st quarter valued at about $1,788,000. Jennison Associates LLC lifted its position in Option Care Health by 76.5% during the first quarter. Jennison Associates LLC now owns 870,588 shares of the company's stock valued at $30,427,000 after acquiring an additional 377,225 shares during the last quarter. Isthmus Partners LLC purchased a new stake in Option Care Health during the first quarter valued at approximately $1,622,000. CWM LLC boosted its stake in Option Care Health by 245.1% in the first quarter. CWM LLC now owns 3,375 shares of the company's stock valued at $118,000 after acquiring an additional 2,397 shares in the last quarter. Finally, Louisiana State Employees Retirement System grew its holdings in Option Care Health by 1.1% in the first quarter. Louisiana State Employees Retirement System now owns 47,700 shares of the company's stock worth $1,667,000 after purchasing an additional 500 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.